Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: May 31, 2018
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: October 19, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026